- Home
- MOGO vs ACXP Comparison
MOGO vs ACXP Comparison
Compare MOGO & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGO
- ACXP
- Stock Information
- Founded
- MOGO 2003
- ACXP 2017
- Country
- MOGO Canada
- ACXP United States
- Employees
- MOGO N/A
- ACXP N/A
- Industry
- MOGO
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- MOGO
- ACXP Health Care
- Exchange
- MOGO Nasdaq
- ACXP Nasdaq
- Market Cap
- MOGO 25.7M
- ACXP 32.0M
- IPO Year
- MOGO N/A
- ACXP 2021
- Fundamental
- Price
- MOGO $1.04
- ACXP $1.91
- Analyst Decision
- MOGO Strong Buy
- ACXP Strong Buy
- Analyst Count
- MOGO 1
- ACXP 1
- Target Price
- MOGO $6.00
- ACXP $12.00
- AVG Volume (30 Days)
- MOGO 23.7K
- ACXP 40.7K
- Earning Date
- MOGO 11-07-2024
- ACXP 11-13-2024
- Dividend Yield
- MOGO N/A
- ACXP N/A
- EPS Growth
- MOGO N/A
- ACXP N/A
- EPS
- MOGO N/A
- ACXP N/A
- Revenue
- MOGO $30,105,578.00
- ACXP N/A
- Revenue This Year
- MOGO N/A
- ACXP N/A
- Revenue Next Year
- MOGO $12.48
- ACXP N/A
- P/E Ratio
- MOGO N/A
- ACXP N/A
- Revenue Growth
- MOGO N/A
- ACXP N/A
- 52 Week Low
- MOGO $0.95
- ACXP $1.52
- 52 Week High
- MOGO $2.25
- ACXP $5.70
- Technical
- Relative Strength Index (RSI)
- MOGO 39.97
- ACXP 38.30
- Support Level
- MOGO $1.00
- ACXP $1.99
- Resistance Level
- MOGO $1.10
- ACXP $2.14
- Average True Range (ATR)
- MOGO 0.04
- ACXP 0.08
- MACD
- MOGO 0.00
- ACXP -0.01
- Stochastic Oscillator
- MOGO 31.43
- ACXP 9.37
About MOGO Mogo Inc.
Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.